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Joint Registry Update
Joint Replacement Registries in the United States:
A New Paradigm
David C. Ayers, MD, and Patricia D. Franklin, MD, MBA, MPH
This commentary serves as an introduction to an upcoming
series of articles about orthopaedic registries, in general, with
an emphasis on lessons learned from the evolving U.S. and
international total joint replacement registries. This paper pro-
vides an overview of total joint replacement registries and the
current expansion of data collection beyond implant attributes
and survival to include postoperative complications and
patient-reported outcomes.
Osteoarthritis is the most common cause of physical dis-
ability in the U.S.1. The combination of osteoarthritis prevalence
and the success of total joint replacement in relieving pain and
improving function in patients with advanced osteoarthritis has
resulted in total joint replacement becoming the most common
and costly inpatient procedure among Medicare beneﬁciaries.
Moreover, the fastest growing subgroup of patients undergoing
total joint replacement consists of those less than sixty-ﬁve years
of age2. More than one million total joint replacements are per-
formed annually in the U.S., making measurement of total joint
replacement outcomes a public health priority. To measure and
monitor the outcomes of total joint replacement, state and na-
tional total joint replacement registries are emerging that incor-
porate lessons learned from long-standing international implant
registries as well as integrate new methods to quantify perioper-
ative quality and patient-reported outcomes.
International total joint replacement registries have tra-
ditionally focused on implant revision rates and tracked the
length of time between the initial total joint replacement and
implant removal. In this model, national registries incorporate
large numbers of arthroplasties to identify relatively low annual
failure rates and the focus is on device longevity. However,
today’s total joint replacement registries are broadening their fo-
cus to include perioperative complications and patient-reported
outcomes following surgery. While the implant revision rate re-
mains an important outcome, implant materials and technology
have matured and patients and insurers want to understand the
quality of care of the vast majority of patients who do not have a
revision each year. Our health-care system is transforming from a
volume-based system to a value-based system. Value is deﬁned as
outcome divided by cost. Measurement of patient outcomes after
total joint replacement is increasingly emphasized.
The 2010 recall of metal-on-metal hip implants brought
total joint replacement into the public eye and reinforced the
importance of recording symptoms such as pain and physical
limitations over time to assess the success of the surgery3. Early
substantial pain in the operatively treated joint was the ﬁrst sign
of metal-on-metal problems. For decades, joint registries only
reported implant data and revision rates, so any implant that
remained in the patient was considered a “success.” However,
as was clear with themetal-on-metal situation, patients who have
not undergone revision may experience symptoms or complica-
tions that must be quantiﬁed. In 2013, the Centers for Medicare
& Medicaid Services (CMS) began publicly reporting thirty-day
hospital readmission rates following total joint replacements. In
early 2014, the CMS added ninety-day all-cause complications to
the hospital reports on total joint replacements. Finally, the CMS
convened a technical expert panel to evaluate the role of patient-
reported outcomes inmonitoring outcomes of total joint replace-
ment in the U.S. Medicare population4.
To meet emerging clinical and policy needs, U.S. total joint
replacement registries must expand beyond implant tracking to
include postoperative complications and patient-reported pain
and function. This same evolution can be observed internation-
ally as the capture and reporting of patient-reported outcomes
following total joint replacement has expanded greatly over the
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past decade. The New Zealand joint registry has been reporting
patient-reported outcome data since 2002 and the Swedish hip
registry, since 20055,6. The U.K. National Health Service (NHS)
began the mandatory collection of patient-reported outcomes in
2009 in an effort to reﬁne the reimbursement system. Patient-
reported outcomes were collected after four types of surgical
procedures, including knee and hip replacement surgery. The
U.K. implant registry ﬁrst integrated the NHS’s patient-reported
outcomes into its 2013 annual report7.
In the U.S., the Agency for Healthcare Research and Qual-
ity awarded a $12 million competitive program project award to
theDepartment of Orthopedics and Physical Rehabilitation at the
University ofMassachusettsMedical School in 2010 to build both
a total joint replacement registry and a total joint replacement
comparative-effectiveness research program1,8. This initiative
(Function and Outcomes Research for Comparative Effective-
ness in Total Joint Replacement [FORCE-TJR]) deﬁnes patient-
reported outcomes as the primary outcome of total joint
replacement. In addition to patient-reported outcomes, the
FORCE-TJR data include postoperative quality measures (e.g.,
thirty-day readmissions, ninety-day complications, and surgi-
cal site infections) as well as implant outcomes (e.g., revision).
All of these measures are important to ensure that U.S. patients
receive the best possible surgical and perioperative care and
achieve optimal outcomes. FORCE-TJR is a patient-centered
total joint replacement registry. Patients choose elective total
joint replacement to relieve pain and improve physical func-
tion. Using patient-reported outcomes to speciﬁcally measure
pain and physical function before and after total joint replace-
ment is a logical method of measuring treatment outcomes
from the patients’ perspective. To date, FORCE-TJR has suc-
cessfully collected patient-reported outcome surveys before
and after total joint replacement to 20,000 patients in diverse
orthopaedic practice settings, including low and high-volume
and urban and rural settings, and supports the importance of
patient-reported outcomes in monitoring total joint replace-
ment outcomes. Ultimately, the FORCE-TJR 30,000-patient
cohort will be the largest national group of patients for whom
complete patient-reported outcome data before and after total
joint replacement will be available. To parallel current U.S.
arthroplasty practice, community-based orthopaedic surgeons
represent 75% of the cohort and are drawn from twenty-two
states. Primary elective total knee and total hip replacements as
well as revision surgery with diverse implant materials and de-
signs are included. FORCE-TJR has collected surveys from 96%
of the patients scheduled to undergo total joint replacement and
patient-reported outcomes from 90% of the patients who have
undergone total joint replacement. Thus, FORCE-TJR can serve
as the reference cohort with which future hospital and physician
outcome data can be compared. Comparative data are returned
to participating surgeons through a secure web site allowing
practices to compare their outcomes with national norms.
In addition to FORCE-TJR, other U.S. total joint replace-
ment registries have emerged. The American Joint Replacement
Registry (AJRR) is an independent, not-for-proﬁt organization
currently collecting implant and basic procedural data from
nearly 140 institutions9. AJRR is now piloting programs to collect
patient-reported outcomes at ﬁfteen sites and postoperative event
data collection. Three state-based total joint replacement regis-
tries have also been established. The Michigan Arthroplasty Reg-
istry Collaborative Quality Initiative (MARCQI) is a consortium
of Michigan hospitals funded by Blue Cross Blue Shield of Mich-
igan. While MARCQI hospitals focused initially on collecting
implant and adverse-event data, a subset of the hospitals collects
patient-reported outcomes. To date, patient-reported outcomes
have been collected from 20% of patients scheduled to undergo
total joint replacement and 10% of those who have undergone
the procedure. The California Joint Replacement Registry (CJRR)
is a collaborative initiative of the California HealthCare Founda-
tion, Paciﬁc Business Group on Health, and California Ortho-
paedic Association to collect total joint replacement outcomes
performed in California. Twenty-four hospitals that perform
about one-quarter of the total joint replacement procedures in
California participate. Patient-reported outcomes and adverse-
event data have been reported by more than 3000 California
patients. This represents approximately 70% of patients sched-
uled to undergo total joint replacement and 30% of those who
have undergone total joint replacement enrolled in this registry10.
Thus, the U.S. total joint replacement registries have addressed
the need for broader post-procedure outcome measurement.
The majority of total joint arthroplasties are performed to
relieve pain and disability of advanced osteoarthritis when com-
prehensive medical and rehabilitation treatments have been ex-
hausted. Patient-reported outcomes offer an objective means to
quantify the trajectory of pain and function both before and after
total joint replacement. In the orthopaedic ofﬁce, osteoarthritic
pathological changes are documented with use of radiographs
and physical examination. While these clinical metrics can quan-
tify osteoarthritis-related cartilage loss and bone changes, neither
can quantify the patient’s experience of pain or the functional
impact of the osteoarthritis. This void is critical because the tim-
ing and importance of total joint replacement are often dictated
by the severity of pain and the extent of disability. To ﬁll this
void, patient-reported outcomes can serve as a new “lab test”
that will complement the radiographs and physical examina-
tion by documenting the patient’s symptoms.
Patient-reported outcomes were developed to be vali-
dated, standardized measures of outcomes that are meaningful
to patients and help surgeons to assess the progression of symp-
tom severity and effectiveness of treatment across time. Patient-
reported outcomes are collected directly from patients. Some are
generic (global) measures that are used for all patients regardless
of their medical conditions. An example of a generic patient-
reported outcome is the Short Form-36 (SF-3611), a thirty-six-item
health questionnaire that includes a global physical component
summary (SF-36 PCS) in which a patient rates how well he/she
performs everyday tasks and a global mental component sum-
mary (SF-36 MCS) in which a patient reports challenges in
emotional health. Of interest, the National Institutes of Health
(NIH)-funded Patient Reported Outcomes Measurement In-
formation System (PROMIS) is establishing a generic core set
of patient-reported outcomes (item bank) that will ultimately
1568
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 96-A d NUMBER 18 d SEPTEMBER 17, 2014
JOINT REPLACEMENT REGISTRIES IN THE UNITED STATES:
A NEW PARADIGM
be available through the Internet and smartphones to reach
large numbers of patients in the future. These types of patient-
reported outcomes are not speciﬁc to a medical condition or
treatment and thus allow comparisons across diverse condi-
tions or treatments.
Other patient-reported outcomes are speciﬁc to a disease
or medical condition and have been validated in speciﬁc patient
populations. For instance, the proprietaryWestern Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)12 has
been validated for patients with osteoarthritis, including those
undergoing total hip or total knee replacement. The WOMAC
assesses clinical changes (pain, stiffness, and function) over
time. The Hip disability and Osteoarthritis Outcome Score
(HOOS) and the Knee injury and Osteoarthritis Outcome
Score (KOOS) are also used for patients undergoing total hip
or knee replacement, and include the WOMAC items plus ad-
ditional items. The non-proprietary HOOS and KOOS13,14 both
include subscores for pain, symptoms, activities of daily living,
sports/recreation function, and quality of life. In the HOOS/
KOOS pain score, for instance, a patient reports how much
pain he/she experiences while performing tasks of daily liv-
ing, and in the HOOS/KOOS activities of daily living score
(function), a patient reports how well he/she can perform
those tasks. The U.S. FORCE-TJR registry uses the HOOS/
KOOS to measure joint-speciﬁc symptoms and performance.
The Oxford15 hip or knee score is a proprietary disease-
speciﬁc patient-reported outcome used in many European
total joint replacement registries. It provides a summed score
that reﬂects the severity of pain and function limitations in
patients treated with total hip or knee replacement. It does not
allow separation of a joint-speciﬁc pain score from a physical
function summary of the same joint and is not used often in
the U.S.
Patient-reported outcomes have been validated in vari-
ous populations to inform population-based norms in the gen-
eral population as well as in patients with a speciﬁc disorder or
medical condition. Condition-speciﬁc norms for patients be-
fore and after surgery are helpful for assessing the timing and
outcomes of the procedures. For example, because FORCE-TJR
has a large national sample of patient-reported outcomes, risk-
adjusted preoperative and postoperative norms can be used by
surgeons to compare his/her patient populations.
In conclusion, total joint replacement registries are emerg-
ing as important surveillance tools with which to assess both
short-term postoperative events and long-term pain relief, func-
tional gain, and revision rates. Over time, this series of reports
will review critical issues related to the use of registry data,
including representative data capture in clinical practice, risk-
adjusted data analysis, and reporting to inform surgeon and
patient clinical decisions. Total joint replacement registries
are rapidly evolving to serve both clinical and public-health
information needs and offer important templates to inform
orthopaedic registries across subspecialties. n
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